Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 3321-3340 of 3,895 trials

PoC in Rheumatoid Arthritis With Methotrexate

NCT00605735

The purpose of this study is to find out if 300 mg of BMS-582949 given once daily will be more effective than placebo after 12 weeks of treatment in subjects with rheumatoid arthritis who are also taking methotrexate

Rheumatoid Arthritis, NOS

Bristol-Myers Squibb121 participantsStarted Mar 2008

Palm Desert, California, United States • Santa Monica, California, United States • Las Vegas, Nevada, United States +25 more locations

COMPLETEDPhase 2< 1 mile

Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

NCT00633789

The purpose of this study is to determine if gastric/esophageal, lung, pancreatic, bladder and sarcoma patients show benefit from brivanib treatment. Patients who clearly do, stay on treatment. Those in which it is unclear will be randomized to continue or withdraw treatment to determine whether that benefit is related to brivanib

Advanced Non-small Cell Lung CancerTransitional Cell CarcinomaSoft Tissue Sarcoma+2 more

Bristol-Myers Squibb597 participantsStarted Jun 2008

Chicago, Illinois, United States • Evanston, Illinois, United States • Baltimore, Maryland, United States +22 more locations

PoC in Rheumatoid Arthritis With Methotrexate

Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

Rheumatoid Arthritis Trials in Other Cities

Relationship Between the Biological and Psychological Correlates of PTSD

Being Responsible for Ourselves HIV Risk Reduction for Black MSM

Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

Effectiveness of Manual Manipulation With EPAT on Ankle Dorsiflexion and Dynamic Plantar Pressure

Treatment of Orthostatic Intolerance in Patients With Parkinson's Disease Using Midodrine

The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial

Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2

A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Familial Intracranial Aneurysm Study II

An Open-Label Study to Evaluate Retreatment With LIPO-202

Burn Outcomes in Young Adult Burn Survivors

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

Complete Occlusion of Coilable Aneurysms

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis

BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy

Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms

Other Conditions in Philadelphia